Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate, Atc J05Ar24 For The Period December 1St, 2023 - November 30Th, 2025